Cargando…
Biomimetic Magnetoliposomes as Oxaliplatin Nanocarriers: In Vitro Study for Potential Application in Colon Cancer
Current chemotherapy for colorectal cancer (CRC) includes the use of oxaliplatin (Oxa), a first-line cytotoxic drug which, in combination with irinotecan/5-fluorouracil or biologic agents, increases the survival rate of patients. However, the administration of this drug induces side effects that lim...
Autores principales: | Garcia-Pinel, Beatriz, Jabalera, Ylenia, Ortiz, Raul, Cabeza, Laura, Jimenez-Lopez, Concepción, Melguizo, Consolación, Prados, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356838/ https://www.ncbi.nlm.nih.gov/pubmed/32599905 http://dx.doi.org/10.3390/pharmaceutics12060589 |
Ejemplares similares
-
Oxaliplatin–Biomimetic Magnetic Nanoparticle Assemblies for Colon Cancer-Targeted Chemotherapy: An In Vitro Study
por: Jabalera, Ylenia, et al.
Publicado: (2019) -
mAb-Functionalized Biomimetic MamC-Mediated-Magnetoliposomes as Drug Delivery Systems for Cancer Therapy
por: Oltolina, Francesca, et al.
Publicado: (2023) -
Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
por: Ortíz, Raúl, et al.
Publicado: (2021) -
Bengamide Analogues Show A Potent Antitumor Activity against Colon Cancer Cells: A Preliminary Study
por: García-Pinel, Beatriz, et al.
Publicado: (2020) -
Magnetoliposomes Based on Shape Anisotropic Calcium/Magnesium Ferrite Nanoparticles as Nanocarriers for Doxorubicin
por: Cardoso, Beatriz D., et al.
Publicado: (2021)